tiprankstipranks
Advertisement
Advertisement

TMDX Stock Latest News

TransMedics Group Ramps Growth With Record Earnings
Company AnnouncementsTransMedics Group Ramps Growth With Record Earnings
9d ago
TMDX
TransMedics Buy Rating Reaffirmed as Analyst Maintains $95 Price Target on Robust Multi-Year Growth Outlook
PremiumRatings
TransMedics Buy Rating Reaffirmed as Analyst Maintains $95 Price Target on Robust Multi-Year Growth Outlook
13d ago
TMDX
TransMedics price target lowered to $77 from $80 at UBS
PremiumThe Fly
TransMedics price target lowered to $77 from $80 at UBS
20d ago
TMDX
TransMedics price target raised to $122 from $120 at Baird
PremiumThe Fly
TransMedics price target raised to $122 from $120 at Baird
20d ago
TMDX
TransMedics price target lowered to $100 from $120 at Piper Sandler
PremiumThe Fly
TransMedics price target lowered to $100 from $120 at Piper Sandler
20d ago
TMDX
TransMedics price target lowered to $95 from $124 at Canaccord
PremiumThe FlyTransMedics price target lowered to $95 from $124 at Canaccord
20d ago
TMDX
TransMedics price target lowered to $65 from $80 at Stifel
Premium
The Fly
TransMedics price target lowered to $65 from $80 at Stifel
20d ago
TMDX
TransMedics reports Q2 adjusted EPS 44c, consensus 48c
Premium
The Fly
TransMedics reports Q2 adjusted EPS 44c, consensus 48c
21d ago
TMDX
TransMedics raises FY26 revenue view to $737M-$757M from $727M-$757M
PremiumThe Fly
TransMedics raises FY26 revenue view to $737M-$757M from $727M-$757M
21d ago
TMDX
TransMedics Group options imply 12.4% move in share price post-earnings
PremiumThe Fly
TransMedics Group options imply 12.4% move in share price post-earnings
21d ago
TMDX
TransMedics price target lowered to $106 from $142 at Needham
PremiumThe Fly
TransMedics price target lowered to $106 from $142 at Needham
22d ago
TMDX
TransMedics Group: Robust Transplant Demand Supports Buy Rating Despite Price Target Cut to $106
PremiumRatings
TransMedics Group: Robust Transplant Demand Supports Buy Rating Despite Price Target Cut to $106
22d ago
TMDX
TransMedics (TMDX): Buy Rating Backed by Accelerating U.S. Organ Transplant Volumes and Expanding OCS Utilization
PremiumRatingsTransMedics (TMDX): Buy Rating Backed by Accelerating U.S. Organ Transplant Volumes and Expanding OCS Utilization
23d ago
TMDX
TMDX Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
TMDX Earnings this Week: How Will it Perform?
24d ago
TMDX
TransMedics Group Lawsuit Ruling: Court Allows Key Investor Claims Over Alleged Forced Bundling to Move Forward 
Premium
Class Action
TransMedics Group Lawsuit Ruling: Court Allows Key Investor Claims Over Alleged Forced Bundling to Move Forward 
27d ago
TMDX
TransMedics initiated with a Neutral at UBS
PremiumThe Fly
TransMedics initiated with a Neutral at UBS
28d ago
TMDX
TransMedics rises 8.0%
PremiumThe Fly
TransMedics rises 8.0%
1M ago
TMDX
TransMedics price target lowered to $90 from $100 at Evercore ISI
PremiumThe Fly
TransMedics price target lowered to $90 from $100 at Evercore ISI
2M ago
TMDX
TransMedics completes strategic investment in PAD Aviation
PremiumThe Fly
TransMedics completes strategic investment in PAD Aviation
2M ago
TMDX
3 Most Shorted Stocks with Up to 275% Upside Potential
PremiumMarket News3 Most Shorted Stocks with Up to 275% Upside Potential
2M ago
ECHO
TMDX
TransMedics benefiting from growth in heart transplant volumes, says TD Cowen
Premium
The Fly
TransMedics benefiting from growth in heart transplant volumes, says TD Cowen
2M ago
TMDX
Analyst Maintains Buy on TransMedics, Keeps Price Target Unchanged at $124 Despite Higher Interest Costs and Dilution
Premium
Ratings
Analyst Maintains Buy on TransMedics, Keeps Price Target Unchanged at $124 Despite Higher Interest Costs and Dilution
2M ago
TMDX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >